Create diverse, relevant, ethical and socially-aware brands for clients, corporations, communities and cultures. MA Graphic Branding and Identity will help you go beyond visual identity, typographical ...

Cell Metabolism, launched in January 2005, is one of the newer titles in the Cell Press family. The journal focuses on physiology, with an emphasis on understanding the molecular basis of how the ...

Batteries die, SD cards get corrupted, settings get messed up, and squirrels trigger thousands of useless images. So why would you make your trail camera strategy more complicated by throwing in ...

Swiss IoT module maker u-blox is to phase out its loss-making cellular IoT business, the firm has said. The division has over 200 employees; jobs are expected to go with its closure. It made revenue ...

The network is called Lunar Surface Communication System (LSCS), and it is basically a replica of the 4G/LTE cellular technology currently used on a very large scale by the humans of Earth.

Two new “pioneering” open-access scale-up facilities focused on advancing cellular agriculture are at the centre of a €12.5m investment grant from the Dutch National Growth Fund for Cellular ...

It looks like T-Mobile is now accepting customers into the free beta program for SpaceX’s cellular Starlink service—but only if you have the latest Samsung handsets. On Tuesday, a number of T ...

A major report has warned that graphic design is one of the jobs most threatened by AI. Every two years, the World Economic Forum (WEF) produces its Future of Jobs report. The 2025 version was just ...

8, 2024. (AP Photo/Ted Shaffrey, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Johnson & Johnson will spend more than $14 billion to delve further into the treatment of ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...